Yohann Bohren Selected Research

Yohann Bohren Research Topics

7	Neuralgia (Stump Neuralgia) 01/2022 - 08/2010
4	Hyperalgesia 02/2015 - 08/2010
2	Hypersensitivity (Allergy) 01/2022 - 10/2014
2	Pain (Aches) 02/2015 - 08/2010
1	Peripheral Nerve Injuries 01/2022
1	Neuroinflammatory Diseases 01/2022

3	CytokinesIBA 01/2022 - 12/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2013
2	Nortriptyline (Aventyl)FDA LinkGeneric 02/2015 - 08/2010
2	Antidepressive Agents (Antidepressants)IBA 02/2015 - 12/2013
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 02/2015 - 08/2010
1	EtazolateIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	zaprinastIBA 01/2022
1	vinpocetineIBA 01/2022
1	ibudilastIBA 01/2022
1	diethylstilbestrol monophosphate (PDES)IBA 01/2022
1	MY 5445IBA 01/2022
1	YM 976IBA 01/2022
1	Sildenafil Citrate (Viagra)FDA Link 01/2022
1	Phosphodiesterase InhibitorsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Theophylline (Theon)FDA LinkGeneric 01/2022
1	Milrinone (Primacor)FDA LinkGeneric 01/2022
1	RolipramIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 01/2022
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 02/2015
1	norbinaltorphimineIBA 02/2015
1	Probenecid (Benemid)FDA LinkGeneric 10/2014
1	Capsaicin (Zostrix)FDA Link 10/2014
1	Polyethylene (Polythene)IBA 11/2011
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2010
1	naltrindoleIBA 08/2010

1	Injections 10/2014